AGL40.03▲ 0.02 (0.00%)AIRLINK129.31▲ 2.31 (0.02%)BOP6.8▲ 0.11 (0.02%)CNERGY4.64▲ 0.13 (0.03%)DCL8.63▼ -0.01 (0.00%)DFML40.95▼ -0.09 (0.00%)DGKC85.74▲ 0.13 (0.00%)FCCL33▼ -0.11 (0.00%)FFBL66.53▲ 0.43 (0.01%)FFL11.46▼ -0.09 (-0.01%)HUBC110.58▼ -0.53 (0.00%)HUMNL14.63▼ -0.19 (-0.01%)KEL5.24▲ 0.07 (0.01%)KOSM8.11▲ 0.45 (0.06%)MLCF40.07▼ -0.14 (0.00%)NBP60.51▲ 0 (0.00%)OGDC195.47▲ 1.37 (0.01%)PAEL27.1▲ 0.38 (0.01%)PIBTL7.64▲ 0.27 (0.04%)PPL155.82▲ 2.03 (0.01%)PRL27.37▲ 1.16 (0.04%)PTC18.56▲ 1.38 (0.08%)SEARL85.1▼ -0.5 (-0.01%)TELE7.9▲ 0.33 (0.04%)TOMCL34.88▲ 0.49 (0.01%)TPLP9.22▲ 0.4 (0.05%)TREET16.81▼ -0.01 (0.00%)TRG62.86▲ 0.31 (0.00%)UNITY27.75▲ 0.46 (0.02%)WTL1.3▲ 0 (0.00%)

Scientists develop new laser that can find, destroy cancer cells in blood

Share
Tweet
WhatsApp
Share on Linkedin
[tta_listen_btn]

CANCER cells can spread to other parts of the body through the blood. And now, researchers have developed a new kind of laser that can find and zap those tumor cells from the outside of the skin.
Though it may still be a ways away from becoming a commercial diagnostic tool, the laser is up to 1,000 times more sensitive than current methods used to detect tumor cells in blood, the researchers reported June 12 in the journal Science Translational Medicine.
To test for cancer spread, doctors typically take blood samples, but often the tests fail to find tumor cells even if they are present in a single sample, especially if the patient has an early form of cancer, said senior author Vladimir Zharov, director of the nanomedicine center at the University of Arkansas for Medical Sciences.
If the tests do come back positive, that typically means there’s a high concentration of circulating tumor cells in the blood; at that point, the cancer has likely spread widely to other organs and it’s often “too late to effectively treat patients,” Zharov added.
Years ago, Zharov and his team came up with the idea of an alternate, noninvasive method to test larger quantities of blood with a greater sensitivity. Tak-ing the familiar route, they tested it in the lab, then on animals and recently brought it to clinical trials in humans.
The new technology, dubbed the Cytophone, uses pulses of laser light on the outside of the skin to heat up cells in the blood.
But the laser only heats up melanoma cells — not healthy cells — because these cells carry a dark pigment called melanin, which absorbs the light.
The Cytophone then uses an ultrasound technique to detect the teensy, tiny waves emitted by this heating effect.
They tested the technology on 28 light-skinned patients who had melanoma and on 19 healthy volunteers who didn’t have melanoma.
They shone the laser onto the patients’ hands and found that within 10 seconds to 60 minutes, the technology could identify circulating tumor cells in 27 out of 28 of those volunteers.
The device didn’t return any false positives on the healthy volunteers, and it didn’t cause safety concerns or side effects, they said.
Melanin is a pigment that is normally present in the skin, but skin cells aren’t harmed, Zharov said.
Even though the skin produces melanin naturally, this laser technique doesn’t harm those cells.

Related Posts

Get Alerts